Zydus Pharmaceuticals Recalls Chlorpromazine Hydrochloride Tablets Due to Contamination
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Product Details
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, available in 50 mg dosage. They are packaged in 100-count bottles. The lot numbers include Z306327, Z306748, Z401154, Z403738, and Z405645.
The Hazard
The recall stems from CGMP deviations, specifically the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake limits. This contamination could pose serious health risks to consumers.
What to Do
Consumers should stop using Chlorpromazine Hydrochloride Tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for further assistance.
Contact Information
For more information, consumers can visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0634-2025.